Stock price when the opinion was issued
Lots of contracts in last year that were EV-related. Recently, EV sales slowed. Market got worried, stock came down. Yesterday, largest shareholder offloaded stock. Good time to buy in mid-high $40s, EVs aren't going away. Probably just delays, no cancellations. Accretive acquisitions in life sciences, which are high margin.
Investors are still fretting about the decline in the backlog, and then its largest shareholder compounded problems by selling a large block of shares. We would remain a HOLD at the current (cheap) valuation and reference this recent answer. We might start picking away with more at the $42 level in any further declines.
Unlock Premium - Try 5i Free
Struggling. The best we can say is that the chart seems finally to be stabilizing. Hard to say whether it needs a washout before the downtrend is over. Trying to bottom, but hasn't picked up yet.
When you ask yourself what could happen, technicians look at a 50% retracement, where a stock would give up half of the move. So, if you went from $15 to $60, that's a $45 gain. Half of that is $22.50. The high of $60 - $22.50 brings you to $37.50, which is close to the 2022 lows.
This is one of his biggest positions. They report growth quarter after quarter. They were a challenged company but they changed management, changed focus to health care sector and cleaned up the balance sheet. They have no net debt. The stock has had a big run-up but the fundamentals have been going up at least as fast. It trades at a discount to US peers even though it has a much better balance sheet. It trades at about 12x EBITDA and peers trade in the mid-teens.